Drug Shortage Report for BRIVLERA
| Report ID | 151585 |
| Drug Identification Number | 02452987 |
| Brand name | BRIVLERA |
| Common or Proper name | BRIVLERA |
| Company Name | UCB CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BRIVARACETAM |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL |
| Packaging size | 300mL |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-12-23 |
| Actual start date | 2022-01-04 |
| Estimated end date | 2022-01-24 |
| Actual end date | 2022-01-18 |
| Shortage status | Resolved |
| Updated date | 2022-01-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-01-19 | English | Compare |
| v5 | 2022-01-18 | French | Compare |
| v4 | 2022-01-18 | English | Compare |
| v3 | 2021-12-24 | English | Compare |
| v2 | 2021-12-20 | French | Compare |
| v1 | 2021-12-20 | English | Compare |
Showing 1 to 6 of 6